Psychiatric resident and faculty views on and interactions with the pharmaceutical industry

Academic Psychiatry

Volumn 34, Issue 2, 2010, Pages 102-108

  Misra, Sahana ^a,b   Ganzini, Linda ^a,b   Keepers, George ^b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; DRUG INDUSTRY; GIFT GIVING; HUMAN; INFORMATION PROCESSING; MEDICAL EDUCATION; MEDICAL SCHOOL; METHODOLOGY; PSYCHIATRY; PUBLIC RELATIONS; STATISTICS; UNITED STATES;

ATTITUDE; DATA COLLECTION; DRUG INDUSTRY; FACULTY, MEDICAL; GIFT GIVING; HUMANS; INTERNSHIP AND RESIDENCY; INTERPROFESSIONAL RELATIONS; OREGON; PSYCHIATRY;

EID: 77949780983     PISSN: 10429670     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ap.34.2.102     Document Type: Article

References (37)

1. Garb S: Teaching medical students to evaluate drug advertising. J Med Educ 1960; 35:729-739
2. Zipkin DA, Steinman MA: Interactions between pharmaceutical representatives and doctors in training: a thematic review. J Gen Intern Med 2005; 20:777-786
3. Lurie N, Rich EC, Simpson DE, et al.: Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990; 5:240-243
4. Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283:373-380
5. Lexchin J: Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J: 1993; 149:1401-1407
6. Adair RF, Holmgren LR: Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 2005; 118:881-884
7. Chren M, Landefeld S: Physicians' behavior and their interactions with drug companies. JAMA 1994; 271:684-689
8. Schwartz TL, Kuhles DJ, Wade M, et al.: Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry 2001; 13:159-162
9. Wofford JL, Ohl CA: Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ 2005; 5:5
10. Bellin M, McCarthy S, Drevlow L, et al.: Medical students exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med 2004; 79:1041-1045
11. Fitz MM, Homan D, Reddy S, et al.: The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry. Acad Med 2007; 82(suppl 10):S1-S3
12. Sierles FS, Brodkey AC, Cleary LM, et al.: Medical students exposure to and attitudes about drug company interactions. JAMA 2005; 294:1034-1042
13. Hyman PL, Hochman ME, Shaw JG, et al.: Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry. Acad Med 2007; 82:94 -99
14. Turner EH, Matthews AM, Linardatos E, et al.: Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358:252-260
15. Ziegler MG, Lew P, Singer BC: The accuracy of drug information from pharmaceutical sales representatives. JAMA 1995; 273:1296-1298
16. Spingarn RW, Berlin JA, Strom BL: When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med 1996; 71:86-88
17. Bowman MA: The impact of drug company funding on the content of continuing medical education. Mobius 1986; 6:66-69
18. Bowman MA, Pearle DL: Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof 1998; 8:13-20
19. Morgan MA, Loewenstein DG, Zinberg S, et al.: Interactions of doctors with the pharmaceutical industry. J Med Ethics 2006; 32:559-563
20. Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J: 1995; 153:553-559
21. Randall ML, Rosenbaum JR, Rohrbaugh RM, et al.: Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Acad Psychiatry 2005; 29:33-39
22. Geppert CM: Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatry training. Acad Psychiatry 2007; 31:32-39
23. American Medical Association Council on Ethical and Judicial Affairs: Code of Medical Ethics: Current Opinions with Annotations. Chicago, American Medical Association, 2004-2005
24. Varley CK, Jibson MD, McCarthy M, et al.: A survey of the interactions between psychiatry residency programs and the pharmaceutical industry. Acad Psychiatry 2005; 29:40-46
25. Brennan TA, Rothman DJ, Blank L, et al.: Health industry practices that create conflict of interest. JAMA 2007; 295:429-433
26. McCormick BB, Tomlinson G, Brill-Edwards P, et al.: Effect of restricting contact between pharmaceutical representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286:1994-1999
27. Coleman DL, Kazdin AE, Miller LA, et al.: Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med 2006; 81:154-160
28. Pollack A: Stanford to ban drug makers' gifts to doctors, even pens. New York Times, Sept 12, 2006, p C2
29. Ward G: Vanderbilt bans most gifts from drug firms. Available at: www.tennessean.com/apps/pbcs.dll/article?AID-2008801310366
30. Campbell EG, Weissman JS, Ehringhaus S, et al.: Institutional academic-industry relationships. JAMA 2007; 298:1779-1786
31. McKinney WP, Schiedermayer DL, Lurie N, et al.: Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA 1990; 264:1693-1697
32. McDonald LL, Davis BM, Milliken GA: A non-randomized unconditional test for comparing two proportions in 2x2 contingency tables. Technometrics 1977; 19:145-157
33. Manly BFJ: Randomization, Bootstrap and Monte Carlo Methods in Biology. London, Chapman & Hall, 1997, pp 1-16
34. R Development Core Team: R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2007. Available at www.R-project.org
35. Brown BW, Spears M, Gutierrez D, et al.: EXTSIG: Exact p-values for 2x2 tables. University of Texas MD Anderson Cancer Center, 1999. Available at http://biostatistics.mdanderson.org/SoftwareDownload
36. Maykut P, Morehouse R: Beginning Qualitative Research: A Philosophic and Practical Guide. London, The Falmer Press, 1994
37. Lichstein PR, Turner RC, O'Brien K: Impact of pharmaceutical company representatives on internal medicine residency programs. Arch Intern Med 1992; 152:1009-1013